Avalo Therapeutics Announces Board Changes and Executive Compensation Updates
Ticker: AVTX · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1534120
| Field | Detail |
|---|---|
| Company | Avalo Therapeutics, INC. (AVTX) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-changes
Related Tickers: AVLO
TL;DR
AVLO board shakeup & comp changes announced 6/17. Watch for new strategy.
AI Summary
Avalo Therapeutics, Inc. announced on June 17, 2025, a series of significant corporate actions. These include the departure of certain directors and officers, the election of new directors, and adjustments to compensatory arrangements for key executives. The company also reported on other events and filed financial statements and exhibits.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future performance, impacting investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can indicate internal shifts that may affect the company's future direction and stability.
Key Numbers
- 001-37590 — SEC File Number (Identifies the company's filing with the SEC.)
- 45-0705648 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Avalo Therapeutics, Inc. (company) — Registrant
- June 17, 2025 (date) — Earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Cerecor Inc. (company) — Former company name
FAQ
Who are the departing directors or officers?
The filing indicates the departure of certain directors or officers but does not specify their names in the provided text.
Who are the newly elected directors?
The filing states the election of directors but does not name the individuals in the provided text.
What specific changes were made to compensatory arrangements?
The filing mentions changes to compensatory arrangements for certain officers but does not detail the specifics in the provided text.
What is the exact date of the earliest event reported?
The earliest event reported is dated June 17, 2025.
What was Avalo Therapeutics' former company name?
Avalo Therapeutics, Inc. was formerly known as Cerecor Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Avalo Therapeutics, Inc. (AVTX).